A nano-targeted co-delivery system based on gene regulation and molecular blocking strategy for synergistic enhancement of platinum chemotherapy sensitivity in ovarian cancer-Reference-Cited by-同舟云学术

A nano-targeted co-delivery system based on gene regulation and molecular blocking strategy for synergistic enhancement of platinum chemotherapy sensitivity in ovarian cancer

Published:2023-06 Issue: Volume:640 Page:123022
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Song Mengdi,Fang Zhou,Wang Jun,Liu Kehai

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition;Baba;Gynecol. Oncol.,2007

2. Reversion of P-gp-mediated drug resistance in ovarian carcinoma cells with PHPMA-Zosuquidar conjugates;Battistella;Biomacromolecules,2017

3. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients;Devarajan;Crit. Rev. Oncol. Hematol.,2021

4. Signalling takes control of nucleo-cytoplasmic trafficking. Workshop on signal-regulated nuclear transport;Greber;EMBO Rep.,2002

5. A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance;Guo;Mater. Sci. Eng. C Mater. Biol. Appl.,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair;Drug Delivery and Translational Research;2024-07-02

2. Nanodrugs based on co-delivery strategies to combat cisplatin resistance;Journal of Controlled Release;2024-06

3. The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers;Current Pharmaceutical Design;2024-04

4. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer;Nanomedicine;2024-01

5. Polyethylenimine: an efficient carrier in cancer therapeutics;Cancer Therapy;2024